Open-Label 24-Week Extension Study of Edaravone (MCI-186) in Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration - United Kingdom
doi 10.1080/21678421.2017.1364269
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Informa UK Limited